TECTONIC THERAPEUTIC, INC. Current Assets
TECTONIC THERAPEUTIC, INC. (TECX) had Current Assets of $231.10 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $231.10M.
- 2026-03-31: Assets, Current $239.89M.
- 2025-12-31: Assets, Current $257.36M.
- 2025-09-30: Assets, Current $273.24M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $231.10M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $239.89M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $257.36M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $273.24M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $290.85M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $309.64M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $146.86M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $162.60M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $187.39M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $91.84M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $30.88M 10-K · filed 2025-03-20 | $100.26M 10-K · filed 2024-03-14 |
| 2023-09-30 | $109.17M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $128.84M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $77.25M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $99.96M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $126.23M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $142.08M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $170.92M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $199.15M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $211.66M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $233.52M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $242.06M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $267.24M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $228.99M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $251.02M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $265.35M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $195.70M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $213.71M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $98.19M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $113.68M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $130.02M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $140.08M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $156.15M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $6.31M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |